Table 1: Baseline characteristics of hypertensive patients with type 2 diabetes and normoalbuminuria according to availability of fundus evaluation YES/NO, evidence of retinopathy at study entry YES/NO, and to randomization to ACE inhibitor therapy YES/NO and ndCCB therapy YES/NO.

Funduscopy YesFunduscopy NoRetinopathy YesRetinopathy NoWith Retinopathy
ACEi YesACEi NondCCB YesndCCB No

Number of patients55065990460424850  40

Demography
 Age (yrs)62.0    ±   7.862.6 ± 8.261.3 ± 7.962.1 ± 7.861.5 ± 7.761.1 ± 8.160.8 ± 8.462.0 ± 7.1
 Males (n)294 (53.5)345 (52.3)48 (53.3)246 (53.5)24 (57.1)24 (50.0)30 (60.0)18 (45.0)
 Clinics
  BMI (kg/m2)28.7 ± 4.529.4 ± 4.9*28.3 ± 4.028.8 ± 4.628.0 ± 3.328.6 ± 4.528.4 ± 4.028.1 ± 4.0
  Diabetes duration (yrs)7.9 ± 6.67.4 ± 6.510.5 ± 7.27.4 ± 6.3°°°11.2 ± 7.59.9 ± 7.110.9 ± 7.010.1 ± 7.6
 Smokers
  Never323 (58.7)377 (57.2)58 (64.4)265 (57.6)24 (57.1)34 (70.8)31 (62.0)27 (67.5)
  Former169 (30.7)194 (29.4)24 (26.7)145 (31.5)14 (33.3)10 (20.8)15 (30.0)9 (22.5)
  Current58 (10.5)88 (13.3)8 (8.9)50 (10.9)4 (9.5)4 (8.3)4 (8.0)4 (10.0)

Laboratory
 HbA1c (%)5.9 ± 1.55.7 ± 1.3**6.5 ± 1.55.8 ± 1.4°°°6.6 ± 1.46.5 ± 1.76.6 ± 1.76.4 ± 1.2
 Systolic BP (mm Hg)151.6 ± 14.3149.3 ± 12.9*158.4±16.5150.3 ± 13.5°°°161.2 ± 15.3155.9±17.2154.3±15.2189.0 ± 55.6
 Diastolic BP (mm Hg)88.8 ± 8.386.4 ± 6.9***90.7 ± 8.288.4 ± 8.3°92.4 ± 7.989.1±8.389.9±8.591.6 ± 7.9
 Albuminuria (μg/min)6.8 ± 4.57.0 ± 4.68.1 ± 5.16.6 ± 4.4°°8.0 ± 5.08.2 ± 5.28.3 ± 5.47.8 ± 4.6
 Ser. creatinine (mg/dL)0.9 ± 0.20.9 ± 0.20.9 ± 0.20.9 ± 0.20.9 ± 0.20.9 ± 0.10.9 ± 0.10.9 ± 0.2
 Triglycerides (mg/dL)143.5 ± 73.2151.7 ± 83.4146.3 ± 75.0142.9 ± 72.9146.7 ± 64.9145.9 ± 83.6139.7 ± 80.1154.4 ± 68.2
 Tot. Cholesterol (mg/dL)212.0 ± 36.5208.5 ± 35.1213.1 ± 40.5211.8 ± 35.7207.7 ± 31.2217.8 ± 46.9209.4 ± 37.3217.7 ± 44.1

Data are mean ± SD or numbers and percentages (in brackets).
* P<  .05, **P<.01, ***P.001 versus Fundoscopy YES; °P<.05, °°P<.01, °°°P.001 versus Retinopathy YES; ^P<.01 versus ndCCB YES.